East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Canagliflozin Tablets, 100 mg and 300 mg. Aurobindo Pharma’s Canagliflozin Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Invokana Tablets, manufactured by Janssen Pharmaceuticals, Inc.

Canagliflozin Tablets are indicated as an:

• Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.